Beyond Antibodies: The DARPin Platform

The DARPin drug platform was established with a imaginative and prescient to develop the medical use of biologics past what was doable with monoclonal antibodies. It’s based mostly on naturally occurring ankyrin repeat domains which might be usually constructing blocks of multifunctional human proteins.

 

The platform permits for the era of various, well-behaved, multifunctional drug candidates. Current scientific knowledge illustrate the favorable security profile of the primary DARPin® molecules examined in sufferers. With the optimistic part III outcomes of essentially the most superior DARPin® drug candidate, abicipar, the DARPin® drug platform is doubtlessly about to realize its first advertising and marketing approval.

               

Genscanner
Genscanner

                     
This assessment highlights a few of the key milestones and selections encountered when reworking the DARPin® platform from an educational idea to a biotech drug pipeline engine.

Coexisting TIF1γ-positive Main Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis: A Case Report

                     

Anti-transcriptional middleman issue 1γ (anti-TIF1γ) antibody-positive dermatomyositis (DM) is strongly related to most cancers, though the mechanism of motion continues to be unclear. We herein describe the primary recognized case of an 80-year-old lady recognized with TIF1γ-positive main pulmonary lymphoepithelioma-like carcinoma (LELC) coexisting with anti-TIF1γ antibody-positive DM.

Rabbit Anti Human RAGE PolyClonal Antibody

MBS1491232-01mL 0.1mL
EUR 335

Rabbit Anti Human RAGE PolyClonal Antibody

MBS1491232-5x01mL 5x0.1mL
EUR 1475

Anti- RAGE C-terminal Human Antibody

GWB-F936C7 0.25 ml Ask for price

RAGE, Human

E34M146H 5 μg
EUR 155

RAGE, Human

MBS8575303-0005mg 0.005mg
EUR 245

RAGE, Human

MBS8575303-5x0005mg 5x0.005mg
EUR 940

Rabbit anti Human AGER/RAGE mAb(CAP)

RM98012 1000μg
EUR 974.19

Anti-Human RAGE Antibody

101-M612 100 µg
EUR 399
Description: Advanced glycation endproducts (AGE) are adducts formed by the nzymatic glycation or oxidation of macromolecules. AGE forms during aging and its formation is accelerated under pathophysiologic states such as diabetes, Alzheimer’s disease, renal failure and immune/inflammatory disorders. Receptor for Advanced Glycation Endoproducts (RAGE), named for its ability to bind AGE, is a multiligand receptor belonging the immunoglobulin (Ig) superfamily. Besides AGE, RAGE binds amyloid βpeptide, S100/calgranulin family proteins, high mobility group B1 (HMGB1, also know as amphoterin) and leukocyte integrins. The human RAGE gene encodes a 404 amino acid residues (aa) type I transmembrane glycoprotein with a 22 aa signal peptide, a 320 aa extracellular domain containing an Ig-like V-type domain and two Ig like Ce-type domains, a 21 aa transmembrane domain and a 41 aa cytoplasmic domain. The V type domain and the cytoplasmic domain are important for ligand binding and for intracellular signaling, respectively. Two alternative splice variants, lacking the Vtype domain or the cytoplasmic tail, are known. RAGE is highly expressed in the embryonic central nervous system. In adult tissues, RAGE is expressed at low levels in multiple tissues including endothelial and smooth muscle cells, mononuclear phagocytes, pericytes, microglia, neurons, cardiac myocytes and hepatocytes. The expression of RAGE is upregulated upon ligand interaction. Depending on the cellular context and interacting ligand, RAGE activation can trigger differential signaling pathways that affect divergent pathways of gene expression. RAGE activation modulates varied essential cellular responses (including inflammation, immunity, proliferation, cellular adhesion and migration) that contribute to cellular dysfunction associated with chronic diseases such as diabetes, cancer, amyloidoses and immune or inflammatory disorders.

Antibody for Human RAGE

SPC-1292D-A565 0.1ml
EUR 432
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to ATTO 565.

Antibody for Human RAGE

SPC-1292D-A633 0.1ml
EUR 432
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to ATTO 633.

Antibody for Human RAGE

SPC-1292D-A655 0.1ml
EUR 432
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to ATTO 655.

Antibody for Human RAGE

SPC-1292D-A680 0.1ml
EUR 432
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to ATTO 680.

Antibody for Human RAGE

SPC-1292D-A700 0.1ml
EUR 432
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to ATTO 700.

Antibody for Human RAGE

SPC-1292D-ALP 0.1ml
EUR 426
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to Alkaline Phosphatase.

Antibody for Human RAGE

SPC-1292D-APC 0.1ml
EUR 430.8
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to APC .

Antibody for Human RAGE

SPC-1292D-APCCY7 0.1ml
EUR 518.4
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to APC/Cy7.

Antibody for Human RAGE

SPC-1292D-DY350 0.1ml
EUR 523.2
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to Dylight 350.

Antibody for Human RAGE

SPC-1292D-DY405 0.1ml
EUR 494.4
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to Dylight 405.

Antibody for Human RAGE

SPC-1292D-DY488 0.1ml
EUR 471.6
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to Dylight 488.

Antibody for Human RAGE

SPC-1292D-DY594 0.1ml
EUR 476.4
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to Dylight 594.

Antibody for Human RAGE

SPC-1292D-DY633 0.1ml
EUR 464.4
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to Dylight 633.

Antibody for Human RAGE

SPC-1292D-HRP 0.1ml
EUR 418.8
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to HRP.

Antibody for Human RAGE

SPC-1292D-P594 0.1ml
EUR 440.4
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to PE/ATTO 594.

Antibody for Human RAGE

SPC-1292D-PCP 0.1ml
EUR 430.8
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to PerCP.

Antibody for Human RAGE

SPC-1292D-RPE 0.1ml
EUR 429.6
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to RPE .

Antibody for Human RAGE

SPC-1292D-STR 0.1ml
EUR 430.8
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to Streptavidin.

Anti Human RAGE Monoclonal Antibody (Clone No. 1C5)

KG134 each
EUR 856.8
Description: The Anti Human RAGE Monoclonal Antibody (Clone No. 1C5) is available in Europe and for worldwide shipping via Gentaur.

RAGE, human recombinant

4271-10 each
EUR 222

RAGE, human recombinant

4271-1000 each
EUR 5018.4

RAGE, human recombinant

4271-50 each
EUR 510

Human RAGE ELISA Kit

E28L0561 96T
EUR 666.67

Human Rage ELISA Kit

EK5367 96 tests
EUR 599

Human RAGE ELISA Kit

EHR0356 96Tests
EUR 625.2

Human RAGE ELISA Kit

55R-1764 1 kit
EUR 717
Description: ELISA kit for detection of RAGE in the research laboratory

Human RAGE ELISA Kit

GWB-SKR245 96 Tests Ask for price

Human Rage ELISA Kit

GWB-HX5B98 1x96 well plate Ask for price

Human Rage ELISA kit

LF-EK50731 1×96T
EUR 790.8

Anti-Human RAGE-1/MOK Nanobody

MBS1568199-01mg 0.1mg
EUR 405

Anti-Human RAGE-1/MOK Nanobody

MBS1568199-5x01mg 5x0.1mg
EUR 1520

Human RAGE Fast ELISA

TBS3247 1x96-well plate
EUR 580
Description: Cell culture Supernate, Plasma/Serum RAGE

Mouse Monoclonal anti-human RAGE

hAP-0520 100ug
EUR 250

Rabbit Anti-Human RAGE Polyclonal

SPC-1292D 0.1ml
EUR 286
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is unconjugated.

Rabbit Anti-Human RAGE Polyclonal

SPC-1292D-A390 0.1ml
EUR 340
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to ATTO 390.

Rabbit Anti-Human RAGE Polyclonal

SPC-1292D-A488 0.1ml
EUR 339
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to ATTO 488.

Rabbit Anti-Human RAGE Polyclonal

SPC-1292D-A594 0.1ml
EUR 339
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to ATTO 594.

Rabbit Anti-Human RAGE Polyclonal

SPC-1292D-BI 0.1ml
EUR 334
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to Biotin.

Rabbit Anti-Human RAGE Polyclonal

SPC-1292D-FITC 0.1ml
EUR 330
Description: A polyclonal antibody for RAGE from Human. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human RAGE. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200). This RAGE antibody is conjugated to FITC.

RAGE (Human) ELISA Kit

EKA52061-5x96T 5x96T Ask for price

RAGE (Human) ELISA Kit

EKA52061-96T 96T
EUR 446.9

RAGE Human ELISA Kit

MBS355275-5x96Tests 5x96Tests
EUR 2415

RAGE Human ELISA Kit

MBS355275-96Tests 96Tests
EUR 535

Recombinant Human RAGE protein

MBS1561370-005mg 0.05mg
EUR 320

Recombinant Human RAGE protein

MBS1561370-01mg 0.1mg
EUR 410

Recombinant Human RAGE protein

MBS1561370-5x01mg 5x0.1mg
EUR 1520

Anti-Human RAGE Antibody (XT-M4)

MBS1569199-01mg 0.1mg
EUR 405

Anti-Human RAGE Antibody (XT-M4)

MBS1569199-5x01mg 5x0.1mg
EUR 1520

Anti-Mouse RAGE Antibody

103-M268 100 µg
EUR 399
Description: Advanced glycation endproducts (AGE) are adducts formed by the nzymatic glycation or oxidation of macromolecules. AGE forms during aging and its formation is accelerated under pathophysiologic states such as diabetes, Alzheimer’s disease, renal failure and immune/inflammatory disorders. Receptor for Advanced Glycation Endoproducts (RAGE), named for its ability to bind AGE, is a multiligand receptor belonging the immunoglobulin (Ig) superfamily. Besides AGE, RAGE binds amyloid βpeptide, S100/calgranulin family proteins, high mobility group B1 (HMGB1, also know as amphoterin) and leukocyte integrins. The mouse RAGE gene encodes a 403 amino acid (aa) residue type I transmembrane glycoprotein with a 22 aa signal peptide, a 319 aa extracellular domain containing a Ig-like V-type domain and two Ig-like Ce-type domains, a 21 aa transmembrane domain and a 41 aa cytoplasmic domain. The V type domain and the cytoplasmic domain are important for ligand binding and for intracellular signaling, respectively. Two alternative splice variants, lacking the Vtype domain or the cytoplasmic tail, are known. RAGE is highly expressed in the embryonic central nervous system. In adult tissues, RAGE is expressed at low levels in multiple tissues including endothelial and smooth muscle cells, mononuclear phagocytes, pericytes, microglia, neurons, cardiac myocytes, and hepatocytes. The expression of RAGE is upregulated upon ligand interaction. Depending on the cellular context and interacting ligand, RAGE activation can trigger differential signaling pathways that affect divergent pathways of gene expression. RAGE activation modulates varied essential cellular responses (including inflammation, immunity, proliferation, cellular adhesion, and migration) that contribute to cellular dysfunction associated with chronic diseases such as diabetes, cancer, amyloidoses, and immune or inflammatory disorders.

Human Rage ELISA kit (4X96T)

LF-EK50732 4×96T
EUR 2690.4

Human RAGE Protein, His Tag

MBS189082-001mg 0.01mg
EUR 245

Human RAGE Protein, His Tag

MBS189082-005mg 0.05mg
EUR 485

Human RAGE Protein, His Tag

MBS189082-5x005mg 5x0.05mg
EUR 1880

Human Rage PicoKine ELISA Kit

EK0827 96 wells
EUR 583.2
Description: For quantitative detection of human Rage in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA).

Human Rage PicoKine ELISA Kit

MBS175971-5x96StripWells 5x96-Strip-Wells
EUR 2755

Human Rage PicoKine ELISA Kit

MBS175971-96StripWells 96-Strip-Wells
EUR 600

Human Renal Tumor Antigen (RAGE) Protein

20-abx068860
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

RAGE ORF Vector (Human) (pORF)

ORF008564 1.0 ug DNA
EUR 114

Recombinant Human RAGE Protein [His]

VAng-2908Lsx-100g 100 µg
EUR 1116
Description: Recombinant Human RAGE (AGER) protein is expressed in E. coli. (Uniprot ID: Q15109)

Recombinant Human RAGE Protein [His]

VAng-2908Lsx-1mg 1 mg
EUR 4134
Description: Recombinant Human RAGE (AGER) protein is expressed in E. coli. (Uniprot ID: Q15109)

Recombinant Human RAGE Protein [His]

VAng-2908Lsx-500g 500 µg
EUR 2700
Description: Recombinant Human RAGE (AGER) protein is expressed in E. coli. (Uniprot ID: Q15109)

RAGE (Human) OmniKine ELISA Kit

MBS9502071-1x96Wells 1x96Wells
EUR 500

RAGE (Human) OmniKine ELISA Kit

MBS9502071-5x96Wells 5x96Wells
EUR 2300

RAGE (Human) Sandwich ELISA Kit

OK-0350 1Kit
EUR 280
Description: RAGE (Human) Colorimetric Sandwich ELISA Kit

Human RAGE(Renal Tumor Antigen) ELISA Kit

ELK1369-48T 48T Ask for price
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human RAGE. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human RAGE. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human RAGE, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human RAGE in the samples is then determined by comparing the OD of the samples to the standard curve.

Human RAGE(Renal Tumor Antigen) ELISA Kit

ELK1369-96T 96T Ask for price
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human RAGE. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human RAGE. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human RAGE, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human RAGE in the samples is then determined by comparing the OD of the samples to the standard curve.

Human RAGE (Renal Tumor Antigen) ELISA Kit

MBS8800371-10x96StripWells 10x96-Strip-Wells
EUR 3130

Human RAGE (Renal Tumor Antigen) ELISA Kit

MBS8800371-48StripWells 48-Strip-Wells
EUR 315

Human RAGE (Renal Tumor Antigen) ELISA Kit

MBS8800371-5x96StripWells 5x96-Strip-Wells
EUR 1710

                       

The prognosis of LELC can solely be made by a surgical lung biopsy, and never by a computed tomography-guided biopsy, due to heavy lymphocytic infiltration. This instructive case reaffirmed the significance of energetic screening for malignancy in sufferers with anti-TIF1γ antibody-positive DM.

                       

Curiously, the outcomes additionally advised that the robust relationship which exists between anti-TIF1γ antibody-positive DM and most cancers is doubtlessly attributable to tumor-derived TIF1γ.

                       

Worth of Space Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies

Targets: To match the frequency of space postrema syndrome (APS) in adults with anti-aquaporin-4 (AQP4) and anti-myelin oligodendrocyte glycoprotein (MOG) antibodies.

                       

Strategies: APS is outlined as acute or subacute, single or mixed, episodic or fixed nausea, vomiting, or hiccups, persisting for not less than 48 h, which can’t be attributed to some other etiology. The presence of APS was investigated in 274 adults with AQP4 antibodies and 107 adults with MOG antibodies from 10 hospitals. ‘

                       

Outcomes: The research inhabitants comprised Korean adults (≥18 years). On the time of illness onset, 14.9% (41/274) adults with AQP4 antibodies had APS, whereas not one of the individuals with MOG antibodies developed APS (p < 0.001). Throughout the course of the illness, 17.2% (47/274) adults with AQP4 antibodies had APS in distinction to 1.9% (2/107) adults with MOG antibodies with APS (p < 0.001).

                       

Anti-Human Resistin

MBS550711-01mg 0.1mg
EUR 260

Anti-Human Resistin

MBS550711-02mg 0.2mg
EUR 335

Human Resistin

90233-A 5 µg
EUR 130
Description: Recombinant Resistin is a disulfide-linked homodimeric protein consisting of two 93 amino acid residues, and migrates as an approximately 20 kDa protein under non-reducing conditions and as a 10 kDa protein under reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Resistin mature chain was expressed in E. coli.

Human Resistin

90233-B 25 µg
EUR 205
Description: Recombinant Resistin is a disulfide-linked homodimeric protein consisting of two 93 amino acid residues, and migrates as an approximately 20 kDa protein under non-reducing conditions and as a 10 kDa protein under reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Resistin mature chain was expressed in E. coli.

Human Resistin

MBS692069-0005mg 0.005mg
EUR 300

Human Resistin

MBS692069-0025mg 0.025mg
EUR 450

Human Resistin

MBS692069-5x0025mg 5x0.025mg
EUR 1725

Human resistin

MBS400069-001mg 0.01mg
EUR 220

Human resistin

MBS400069-005mg 0.05mg
EUR 545

Human resistin

MBS400069-01mg 0.1mg
EUR 770

                      

Conclusions: APS, one of many core scientific traits of people with AQP4 antibodies, is an especially uncommon manifestation in Korean adults with MOG antibodies.